🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2002-05
Trial ID
NCT00055614
Treatments Being Tested
This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Status
Recruiting
Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Start Date
2025-04-30
Trial ID
NCT06911684
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
This is a randomized, controlled, multicenter clinical study that enrolled ...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-05-01
Trial ID
NCT07560358
This phase II clinical trial is evaluating whether adding KRC-01 injections...
Status
Not Yet Recruiting
Location
Gustave Roussy
Start Date
2026-07
Trial ID
NCT07622017
Treatments Being Tested